Quebec IBD Research Conference – Preliminary Program –

Wednesday, May 21st: 8:30am-5:45 pm @ the CR-CHUM  SESSION 1: IBD disease risk. Co-chairs: Marika Sarfati (CR-CHUM) et François Boudreau (Université de Sherbrooke)  PLENARY:  Mark J. Daly, Broad Institute & Massachusetts General Hospital  Invited talk: Corinne Maurice, McGill University  Invited talk: Martin Pelletier, Université Laval  Trainee presentation: to be selected from abstracts  Panel discussion (all presentersContinue reading “Quebec IBD Research Conference – Preliminary Program –”

iGenoMed-MTT: A Prospective Multi-omic Clinical Study of Response to Molecularly-Targeted Therapies in IBD

Project Summary: At the core of the iGenoMed-MTT Project is a multi-center prospective clinical study of response to advanced therapies in IBD. Biological samples are taken just prior to initiation of a Molecularly Targeted Therapy or MTT as well as at the first follow-up visit when an individual’s response is assessed. In this study, patientsContinue reading “iGenoMed-MTT: A Prospective Multi-omic Clinical Study of Response to Molecularly-Targeted Therapies in IBD”